October2020 Ddhchat Twitterchat Iffgd Taomprakash Nshah Nutrition For Ileostomy The Dietitian And Patient Perspective Script
DDH Chat
Gastroparesis Advocate, Patient Education and Advocacy Specialist with the Association of Gastrointestinal Motility Disorders (AGMD), and IFFGD Patient Advisory Committee member, Melissa Adams VanHouten, talks about amplifying the voice of the gastroparesis community during Gastroparesis Awareness Month in August through a grassroots campaign to establish official proclamations in cities and states across the nation. Gastroparesis, […]
DDH Chat
For those living with congenital sucrase-isomaltase deficiency (CSID), access to needed medical therapies often comes at a high cost. To help alleviate some of the financial burden faced by affected individuals and their families, the HealthWell Foundation has launched a new fund that will provide up to $10,000 in copayment or premium assistance to eligible […]
DDH Chat
Diet & Digestive Health (DDHChat) Twitter Chat with IFFGD, Tina Aswani Omprakash, and Neha D. Shah MPH, RD, CNSC, CHES The Diet & Digestive Health (#DDHChat) Twitter chat series with the International Foundation for Gastrointestinal Disorders (IFFGD), co-host Tina Aswani Omprakash and lead host dietitian Neha D. Shah, MPH, RD, CNSC, CHES. We are excited […]
DDH Chat
Gastroparesis Advocate Shares the Importance of Finding Your Community IFFGD talks to gastroparesis advocate and IFFGD Patient Advisory Committee member, Stephanie Torres, about her journey and the importance of finding your voice and your community. For many, the journey from symptom onset to long-term symptom management is a long and winding one, taking twists and […]
Testimony
On September 12, 2017, Ceciel Rooker presented the following research information to the US Food and Drug Administration (FDA) concerning the burdens and needs of gastroparesis patients: On behalf of the International Foundation for Functional Gastrointestinal Disorders (IFFGD), we appreciate the opportunity provided by the FDA to hear the patient perspective at the Patient-Focused Drug […]
Testimony
The following written comments were submitted to the Office of Disability Policy of the Social Security Administration (SSA) by IFFGD President, Ceciel T. Rooker, in response to Docket No. SSA-2017-0042 on September 23, 2019. Thank you for your leadership at the Office of Disability Policy. The International Foundation for Gastrointestinal Disorders (IFFGD) is grateful for the […]
Testimony
IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with an October 16, 2012 meeting of the Gastrointestinal Drugs Advisory Committee to consider the new drug application (NDA) 203441 by NPS Pharmaceuticals for the drug with the proposed trade name GATTEX® (teduglutide) for the treatment of adult patients with […]
Testimony
On December 2, 2010, Dane Christiansen provided the following testimony on behalf of IFFGD members to the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee regarding the consideration of the Ocean Theapeutics’ product Solesta for the treatment of incontinence: Good afternoon. My name is Dane Christiansen and I am here today representing […]
Testimony
IFFGD President and Co-Founder, Nancy J. Norton submitted the following written statement on October 25, 2012 to the Food and Drug Administration Division of Dockets Management in response to docket number: FDA-2012-N-0967, the Prescription Drug User Fee Act Patient-Focused Drug Development Meeting: Thank you for the opportunity to present the views of the International Foundation […]
The International Foundation for Gastrointestinal Disorders (IFFGD) is now accepting applications for the IFFGD 2026 Preceptorship Award. At IFFGD, our mission is deeply patient-centered — we are committed to improving the lives of those affected by gastrointestinal (GI) disorders. This award supports that mission by investing in the next generation of clinicians and researchers who […]